Aim: Recent epidemiological studies indicate increases in hospital food allergy-related anaphylaxis admission rates in Australian and New Zealand. The aim of the study was to examine whether non-IgE-mediated food allergy might have increased in parallel. Methods: We analysed childhood hospital admissions rates by ICD 10 codes for allergic gastroenteritis (AG) and infective gastroenteritis in Australia and New Zealand between June 1998 and July 2014. Results: In Australia, most AG-related admissions (73%) occurred in those aged <1 year and increased by 7.3%/year (95% confidence interval (CI) 5.5-9.3, P < 0.0001) from 6.8 to 26.5/10 5 population. Similar trends were observed for New Zealand; 81% of admissions occurred in those aged <1 year and increased by 9.4%/year (95% CI 5.5-9.3, P < 0.0001) from 7.2 to 30.7/10 5 population. By contrast there were no significant changes in AG-related admission rates in the older patients and infective gastroenteritis admissions fell in both countries in those aged <1 year; Australia by 4.4%/year (95% CI 4.3-4.6, P < 0.0001) and in New Zealand by 5.8%/year (95% CI 5.4-6.2, P < 0.0001).
1 IgE-mediated childhood food allergy has increased over the last 20 years in Australia and New Zealand. 2 It is unknown whether non-IgE-mediated food allergy has increased as well.
What this paper adds
1 Hospital admissions for allergic gastroenteritis (but not infective gastroenteritis) increased fourfold between 1998 and 2014. 2 If this represents a true increase (and not greater recognition), it remains uncertain whether the same risk factors for IgE-mediated food allergy are relevant for non-IgE-mediated food allergy.
Epidemiogical data (e.g. hospitalisation rates) indicate that IgEmediated food allergy (FA) and anaphylaxis has increased over the past two decades. 1, 2 With the possible exception of eosinophilic esophagitis 3 and coeliac disease, it is unclear whether other non-IgE-mediated FA may have increased as well. 'Allergic gastroenteritis' (AG) as classified under the International Statistical Classification of Diseases (ICD-10) encompasses a number of nonIgE-mediated allergic conditions, including food protein-induced enterocolitis syndrome (FPIES), eosinophilic enteritis and colitis, food protein-induced enteropathy, 'other allergic dietetic gastroenteritis and colitis', food hypersensitivity enteritis and colitis (but specifically not eosinophilic oesophagitis or coeliac disease). We sought to determine whether AG-related paediatric hospital admission rates have increased in parallel with increases in foodrelated IgE-mediated anaphylaxis in Australia and New Zealand.
Methods
We 
Results
Hospital admissions for AG increased over the study period in Australia and New Zealand. In Australia, most AG-related admissions (73%) occurred in those aged <1 year with slight male predominance (58%) and increased by 7.3%/year (95% confidence interval (CI) 5.5-9.3, P < 0.0001) from 6.8 to 26.5/10 5 population (Table 1, Fig. 1a ). Similar trends were observed in New Zealand AG-related admissions; 81% occurred in those aged <1 year with slight male predominance (59%) and increased by 9.4%/year (95% CI 5.5-9.3, P < 0.0001) from 7.2 to 30.7/10 5 population (Fig. 1b) .
By contrast there were no significant changes in AG-related admission rates in the two older age groups in either country (Table 1) .
When infective gastroenteritis admissions were examined as comparators, these decreased in Australia by 4.4%/year (95% CI 4.3-4.6, P < 0.0001) and in New Zealand by 5.8%/year (95% CI 5.4-6.2, P < 0.0001) in those aged <1 year. In Australia there was a minor decrease in all-cause admissions of 0.1%/year (95% CI 0-0.1, P = 0.0001).
Discussion
We report a fourfold increase in AG-related hospital admission rates for AG in Australia and New Zealand in infants aged <1 year between 1998-1999 and 2013-2014. These trends (with slight male predominance and very similar rates between the two countries) could not be explained by increase in overall hospitalisation rates, or consistent changes in admission rates for potentially mimicking conditions such as infective gastroenteritis admissions, which decreased over the period of observation (likely related to update of rotavirus immunisation). AG-related admissions were almost absent in older Australasian age groups.
Many epidemiological studies rely upon ICD coding to track changes in rates of disease, or changes of distribution and burden of diseases within populations. In addition to the many potential caveats involved in using coding data of this nature 3 there are as yet unresolved questions about exactly what the K52.2 ICD code represents in practice and how coders are interpreting admissions data to make this decision about the admission. Accurate coding also relies upon the diagnostic expertise of the health professionals making the diagnosis during the hospital admission. The code is designed to identify FPIES, eosinophilic enteritis and colitis, food protein-induced enteropathy, food hypersensitivity enteritis and colitis but specifically not eosinophilic oesophagitis or coeliac disease. While it would have been informative to examine more detailed disease-specific codes, such data is not available for Australia or New Zealand at this time. Overall, our data suggest a possible increase in non-IgEmediated FA-related disorders such as has been already reported with eosinophilic esophagitis diagnostic rates 3 and is consistent with reports of increasing FPIES presentations to large allergy referral centres in Australia 4 and Italy 5 although not the USA. While it is interesting to speculate that the increase in infant AG admissions might represent FPIES, with increase in infants presenting with the profuse vomiting, pallor and hypotension characteristic of FPIES requiring admission (rather than emergency department assessment and discharge), such conclusions are precluded by the limitations of coding data and thus inability to differentiate from other related conditions (e.g. food-induced enteropathy with failure to thrive) or mimicking conditions (infective gastroenteritis). The observation that rates of admission for AG in both countries for the <1 year age group were very similar is supportive of the possibility that the majority of these cases represent FPIES. If the increase in AG is confirmed by other studies, and not an solely an artefact of improved recognition of disorders such as FPIES 7 and coding, it will be of interest to determine if factors thought to contribute to the increase in IgE-mediated FA 8 might also play a role in non-IgE-mediated gastroenterological FA syndromes.
Conclusion
We present preliminary evidence that non-IgE mediated FA related disorders may be increasing in early childhood. It is uncertain whether risk factors thought to play a role in IgE-mediated FA are relevant in these disorders. 
